SY3-23330-82544
2 vaccinations
2 coded responses
16 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 226 / VA
- Registered
- 2021-06-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-20
Dose 1 — Pfizer-BioNTech
-
2021-06-03
Registered in v-safe
- 2021-06-03
-
2021-06-10
Dose 2 — Pfizer-BioNTech
- 2021-06-10
-
2021-06-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · Fatigue or tirednessAdult check-in
- 2021-06-13
- 2021-06-14
-
2021-06-15
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: Fair · Headache, NauseaFree text: Slight sore throat!MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-16
- 2021-06-17
- 2021-06-24
- 2021-07-01
- 2021-07-08
- 2021-07-15
- 2021-07-22
- 2021-09-09
- 2021-12-10
-
2022-06-10
Survey response — 12 months, dose 2MedDRA: Heavy menstrual bleeding — Feeling: GoodFree text: Heavy PeriodsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-20 | Pfizer-BioNTech | |
| 2 | 2021-06-10 | Pfizer-BioNTech |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Slight sore throat!
Release 12 — 12 months, dose 2
Symptoms: Heavy Periods
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release